0000914475-24-000006.txt : 20240104
0000914475-24-000006.hdr.sgml : 20240104
20240104182612
ACCESSION NUMBER: 0000914475-24-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RASTETTER WILLIAM H
CENTRAL INDEX KEY: 0001205903
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 24513736
MAIL ADDRESS:
STREET 1: 9885 TOWNE CENTRE DR.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330525145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
wk-form4_1704410754.xml
FORM 4
X0508
4
2024-01-02
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001205903
RASTETTER WILLIAM H
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
1
Common Stock
2024-01-02
4
M
0
20000
12.98
A
62785
D
Common Stock
2024-01-02
4
S
0
11044
131.4675
D
51741
D
Non-Qualified Stock Option
12.98
2024-01-02
4
M
0
20000
12.98
D
2024-05-22
Common Stock
20000
0
D
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $130.76 to $133.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
42,785 of the reported shares are held by the Rastetter Family Trust established September 2, 2010, of which the Reporting Person has voting and investment power
The option was granted May 22, 2014 and vested in 12 equal monthly installments beginning June 22, 2014. These options will expire ten years from the date of grant on May 22, 2024.
/s/ Darin Lippoldt, Attorney-in-Fact
2024-01-04